Introduction
============

Retinitis pigmentosa (RP) belongs to a group of inherited retinal diseases with the initial symptom of night blindness and progressive visual field loss and even irreversible blindness, characterized by the sequential degeneration of photoreceptors and RPE \[[@r1],[@r2]\]. The prevalence of RP in China is about 1 in 1,000 \[[@r1],[@r2]\]. RP is a complex disease with clinical variability, genetic heterogeneity, and the existence of modifier genes \[[@r3]\]. The inheritance patterns of RP can be classified as autosomal dominant, autosomal recessive, X-linked, digenic, and mitochondrial \[[@r2]\]. To date, 58 genes and loci have been identified for autosomal recessive RP ([RetNet](https://www.sph.uth.tmc.edu/RetNet/)) including *ABCA4*, *CDHR1*, *CERKL*, *CNGA1*, *CNGB1*, *CRB1*, and *EYS* \[[@r2],[@r4]\]. *EYS* variants account for approximately 5--10% of all autosomal recessive RP patients, while other genes are responsible for 1--2% \[[@r1],[@r5]-[@r7]\]. The autosomal recessive RP genes are involved in various biological functions, including cell metabolism, the phototransduction cascade, cell signaling, RNA and protein modification, and phagocytosis \[[@r3]\]. Identification of the disease-causing mutations in RP patients helps elucidate the genetic architecture and pathogenesis of RP, facilitating the development of novel treatments for RP patients \[[@r4],[@r8]-[@r10]\].

With the rapid development of next-generation sequencing technology, whole exome sequencing (WES) analysis has been applied for identifying variants in exons and splicing sites at the genome-wide scale \[[@r4]\]. The mutations identified in exons or splicing sites are responsible for more than 85% of the disease-associated variants \[[@r8]\]. In this study, we aimed to delineate the disease-causing mutations in three RP families and sporadic RP patients by WES analysis. The identified mutations were also investigated by bioinformatics analyses.

Methods
=======

Study subjects and clinical examinations
----------------------------------------

This study was approved by the Ethics Committee of the Joint Shantou International Eye Center (JSIEC) of Shantou University and the Chinese University of Hong Kong, and it was performed in accordance with the Declaration of Helsinki. Informed consent was obtained from all the study subjects before recruitment. Three Chinese RP families (RP-F1--3), 139 sporadic RP patients, and 200 senile cataract controls were recruited in this study. Complete ophthalmic examinations were conducted, including visual acuity, fundus photography, visual ﬁeld test, slit-lamp examination, optical coherence tomography (OCT) and full-ﬁeld electroretinogram (ERG). Peripheral blood samples were collected in all study subjects.

WES analysis
------------

Genomic DNA from the whole blood was extracted by the TIANGEN Blood DNA kit DP318 (TIANGEN, Beijing, China) according to the manufacturer's protocol. The genomic DNA of four affected patients and two unaffected family members from the three RP families ([Figure 1](#f1){ref-type="fig"}) and 139 sporadic RP patients were subjected to WES analysis (ANOROAD, Beijing, China). Briefly, sequencing libraries were prepared using the SureSelect XT Target Enrichment Kit (Agilent Technologies, Santa Clara, CA) and captured using the Agilent Sure Select Human All Exon Kit V5 (Agilent Technologies). Paired-end sequencing was conducted using the HiSeq 2500PE100 platform (Illumina, San Diego, CA) with a read length of 100 bp and average coverage depth of at least 100X for each sample.
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Mutation analyses
-----------------

All reads from the WES analysis were aligned to the human genome (GRCh37/hg19) with an alignment tool, [BWAMEM](https://github.com/lh3/bwa). The reads with low-mapping quality, PCR duplication, low alignment score and mismatch rate, or high suboptimal alignment score and mismatch rate ≥5% were removed with an in-house program. The candidate single-nucleotide polymorphism (SNPs) and insertion/deletion variants were identified with multiple filtering steps: First, high-frequency variants minor allele frequency (MAF ≥ 0.05) in the [1000 Genome](ftp://ftp.1000genomes.ebi.ac.uk/vol1/ftp/) project and [EXAC](http://exac.broadinstitute.org/), intergenic variants, intronic variants, and synonymous variants were excluded. Second, the potential variants in the reported RP genes were compared with the [RetNET](http://www.sph.uth.edu/retnet/) database. Finally, the candidate variants were further analyzed by Polymorphism Phenotyping v2 ( [Polyphen-2](http://genetics.bwh.harvard.edu/pph2/)) Sorting Intolerant from Tolerant ([SIFT](https://sift.bii.a-star.edu.sg/)), and [Mutation Taster](http://www.mutationtaster.org/) to predict the potential effect on the protein function.

Sanger sequencing confirmation
------------------------------

The identified novel variants were validated by PCR and Sanger sequencing analysis in the remaining affected and unaffected family members. PCR was performed in BioRad PCR machines with specific primers ([Table 1](#t1){ref-type="table"}). The PCR products were purified (Omega, GA) and sequenced by Guangzhou IGE Biotechnology Ltd. (Guangzhou, China). The cosegregation pattern was analyzed in the RP families. The identified variants were confirmed with 200 control subjects by Sanger sequencing.

###### Primers and Usage for EYS confirmation.

  Primer name   Sequence(5′-3′)           Usage
  ------------- ------------------------- --------------------------
  EYS-F1F1      GTTTGTGGAAGTGACGAAGGA     PCR-Confirmation
  EYS-F1R1      AAGCTGACGGAACTCCTGAA      
  EYS_F1F2      CAACTTGGCCAGAAACAGCA      PCR-Confirmation
  EYS_F1R2      TCACCTACATTTGAGCCACCT     
  EYS-F2F       ACTGAAAACATCTTAGGAGGCT    PCR-Confirmation
  EYS-F2R       ACTTCTGTCAGCCCCTCT        
  EYS-41F       AGGCTCCCAGAGATGAAGTC      PCR-Confirmation
  EYS-41R       TGACAAGTTAGCATCAGGGC      
  EYS-1F        AGGGCTTCTAAATTCATACGCA    c.8301dupT:p.D2767fs
  EYS-1R        TCTTTCTCTCCTTCCCTCAGC     
  EYS-2F        ACAATCAGAACCTTCAGTGACA    c.9437_9440del:p.E3146fs
  EYS-2R        GTGGCTCTAAACTATGATGGCA    
  EYS-3F        GCACCAACTCTTCCTGCTTT      c.G8297C:p.G2766A
  EYS-3R        TCAATGAGAACTGTCCACAACT    
  EYS-4F        ACATGCATCAAGTTCCTGGC      c.C490T:p.R164X
  EYS-4R        TGTTCCCCAGATTTGCCCT       
  EYS-5F        GCCATCATAGTTTAGAGCCACA    c.T9052C:p.W3018R
  EYS-5R        GTGTACTTTGGGTTGGGTGG      
  EYS-6F        GGAGACCAATTGCCAGAAAATC    c.T8907G:P.C2969W
  EYS-6R        GCAGAAATGGAGGTGAATGTACA   

Results
=======

Clinical characteristics of the RP patients
-------------------------------------------

The fundus photographs of the proband from RP-F1 showed typical RP phenotypes, with the bone-spicule pigmentation of the retina and waxy pallor optic disc ([Figure 2A,B](#f2){ref-type="fig"}). The OCT analysis presented the disappearance of the photoreceptor layer ([Figure 2C,D](#f2){ref-type="fig"}), and the visual field test indicated a visual field defect ([Figure 2E,F](#f2){ref-type="fig"}). The ERG analysis showed no response to the stimulus for both cone and rod photoreceptors ([Figure 2G,H](#f2){ref-type="fig"}). The affected members in RP-F2 and RP-F3, as well as the sporadic RP patients, showed similar RP phenotypes ([Table 2](#t2){ref-type="table"}), whereas the unaffected family members and control subjects did not present any RP phenotype. The parents and children of the affected study subjects were not diagnosed with RP, indicating the autosomal recessive inheritance in the three recruited families ([Figure 1](#f1){ref-type="fig"}).

![Clinical information for the proband of retinitis pigmentosa family 1 (RP-F1). **A,B**: Fundus picture of the right (A) and left (B) eyes. **C,D**: Optical coherence tomography (OCT) scans of the right (C) and left (D) eyes. **E,F**: Visual fields of the right (E) and left (F) eyes. **G,H**: Electroretinogram (ERG) results of the right (E) and left (F) eyes.](mv-v25-35-f2){#f2}

###### Clinical information of retinitis pigmentosa patients in the included pedigrees.

  Patient                 F1-II:3      F1-II:8   F2-II:3      F2-II:6      F3-II:5
  ----------------------- ------------ --------- ------------ ------------ ----------
  Gender                  Female       Male      Male         Female       Female
  Age of diagnosis        44           35        32           28           61
  Visual acuity OD        HM           FC        0.6          0.6          0.3
  Visual acuity OS        HM           FC        0.8          0.6          0.3
  Macular dystrophy OD    Severe       Severe    Mild         Mild         Mild
  Macular dystrophy OS    Severe       Severe    Mild         Mild         Mild
  Optic disc OD           Waxy         Waxy      Mild         Mild         Waxy
  Optic disc OS           Waxy         Waxy      Mild         Mild         Waxy
  Artery attenuation OD   Yes          Yes       Mild         Mild         Yes
  Artery attenuation OS   Yes          Yes       Mild         Mild         Yes
  Pigment deposits OD     Yes          Yes       Mild         Mild         Yes
  Pigment deposits OS     Yes          Yes       Mild         Mild         Yes
  Electroretinogram OD    Diminished   NA        Diminished   Diminished   NA
  Electroretinogram OS    Diminished   NA        Diminished   Diminished   NA
  Visual Field MD OD      −33.30 db    NA        −32.46 db    −31.54 db    NA
  Visual Field MD OS      −33.31 db    NA        −33.19 db    −33.39 db    NA
  OCT OD                  ISe loss     NA        NA           ISe loss     ISe loss
  OCT OS                  ISe loss     NA        NA           ISe loss     ISe loss

MD: mean defect; OCT: optical coherence tomography; HM: hand movement; FC: finger counting; NA: not available; ISe: inner segment ellipsoid zone.

WES analysis in RP families
---------------------------

Each WES analysis resulted in a total of 12 GB of sequence data, and 95.5% of the sequence reads originated from the exons, with a mean coverage of 100-fold. The total numbers of variants (SNPs and indels) of exons and splice sites identified were as follows: 25,403 for RP-F1-II:3, 25,554 for RP-F1-II:8, 25,523 for RP-F1-I:2, 25,583 for RP-F1-I:1, 23,148 for RP-F2-II:2, and 23,846 for RP-F3-II:5 ([**Figure 3**](#f3){ref-type="fig"}). After filtering the synonymous, intergenic, intronic, and common variants, the candidate variants of known RP genes in recessive inheritance were reduced to two for RP-F1, three for RP-F2, and two for RP-F3.

![Pipeline of mutation screening for whole exome sequencing (WES) data.](mv-v25-35-f3){#f3}

For the family RP-F1, two compound heterozygous variants in *EYS* gene were identified in the two affected members (RP-F1-II:3 and RP-F1-II:8), namely a missense variant c.7492G\>C:p.Ala2498Pro in exon 38 and a missense variant c.8422G\>A:p.Ala2808Thr in exon 43 ([Table 3](#t3){ref-type="table"}). Their unaffected parents (RP-F1-I:1 and RP-F1-I:2) and the unaffected third-generation male subjects (RP-F1-III:3 and RP-F1-III:4) only carried either one of the heterozygous *EYS* variant, and the remaining unaffected members (RP-F1-II:1 and RP-F1-II:6) did not carry any *EYS* variants ([Figure 1](#f1){ref-type="fig"}). These findings indicated that the two *EYS* variants followed the cosegregation pattern of recessive inheritance. The c.8422G\>A:p.Ala2808Thr variant has been previously reported (rs111991705), whereas the c.7492G\>C:p.Ala2498Pro *EYS* variant was neither found in the [1000 genome](http://www.internationalgenome.org/) and dbSNP nor previously reported, suggesting that it is a novel mutation. Furthermore, these two variants were not found in 200 control subjects from our cohort. Therefore, compound heterozygous c.7492G\>C:p.Ala2498Pro and c.8422G\>A:p.Ala2808Thr variants should be the causative mutations for the family RP-F1.

###### Identiﬁed variants in recessive inheritance, population frequencies, and in silico predictions of pathogenic function.

  Family   Gene   Nucleotide /Amino acid change   Previously reported   Variant type   ExAC frequency   SIFT   Polyphen2   MT   Genotypes
  -------- ------ ------------------------------- --------------------- -------------- ---------------- ------ ----------- ---- --------------
  RP-F1    EYS    NM_001292009:exon44:            rs111991705           Missense       0.0098           T      P           N    Heterozygous
                  c.8422G\>A:p.Ala2808Thr                                                                                        
           EYS    NM_001292009:exon38:            Novel                 Missense       Absent           D      D           D    Heterozygous
                  c.7492G\>C:p.Ala2498Pro                                                                                        
  RP-F2    EYS    NM_001292009:exon41:            PMID:24652164         Nonsense       Absent           .      .           .    Homozygous
                  c.8012T\>A:p.Leu2671X                                                                                          
           EYS    NM_001292009:exon31:            PMID:25753737         Missense       0.00005274       D      D           D    Homozygous
                  c.6416G\>A:p.Cys2139Tyr                                                                                        
           RPGR   NM_000328:exon11                rs182345461           Missense       0.0001           T      D           N    Homozygous
                  c.C1282G:p.Leu428Val                                                                                           
  RP-F3    EYS    NM_001292009:exon41:            PMID:24652164         Nonsense       Absent           .      .           .    Heterozygous
                  c.8012T\>A:p.Leu2671X                                                                                          
           EYS    NM_001292009:exon31:            PMID: 25,753,737      Missense       0.00005274       D      D           D    Heterozygous
                  c.6416G\>A:p.Cys2139Tyr                                                                                        

For the family RP-F2, two homozygous variants in the *EYS* gene and one homozygous variant in the *RPGR* gene were identified in the affected member (RP-F2-II:3), as follows: a nonsense *EYS* variant c.8012T\>A:p.Leu2671X in exon 41, a missense *EYS* variant c.6416G\>A:p.Cys2139Tyr in exon 31 and a missense RPGR variant c.C1282G:p.Leu428Val in exon 11 ([Table 3](#t3){ref-type="table"}). The affected sister (RP-F2-II:6) also carried the homozygous *EYS* variants of c.8012T\>A:p.Leu2671X and c.6416G\>A:p.Cys2139Tyr, while the unaffected parents (RP-F2-I:1 and RP-F2-I:2) carried the heterozygous *EYS* variants ([Figure 1](#f1){ref-type="fig"}). These results suggested that the two *EYS* variants were on the same allele, and the cosegregation pattern of recessive inheritance was confirmed. Both c.8012T\>A:p.Leu2671X and c.6416G\>A:p.Cys2139Tyr variants have been previously reported, and they were not found in 200 control subjects from our cohort. Therefore, compound homozygous c.8012T\>A:p.Leu2671X and c.6416G\>A:p.Cys2139Tyr variants should be the causative mutations for the family RP-F2.

For the family RP-F3, two compound heterozygous variants in the *EYS* gene were identified in the affected member (RP-F3-II:5): the nonsense *EYS* variant c.8012T\>A:p.Leu2671X in exon 41 and missense *EYS* variant c.6416G\>A:p.Cys2139Tyr in exon 31 ([Table 3](#t3){ref-type="table"}). Her unaffected parents (RP-F3-I:1 and RP-F3-I:2) only carried either one of the heterozygous *EYS* variants ([Figure 1](#f1){ref-type="fig"}). This indicated that the two *EYS* variants were on different alleles and followed the cosegregation pattern of recessive inheritance. Therefore, compound heterozygous c.8012T\>A:p.Leu2671X and c.6416G\>A:p.Cys2139Tyr variants should be the causative mutations for the family RP-F3. Sanger sequencing analysis has confirmed all identified variants in the affected patients ([Figure 4](#f4){ref-type="fig"}), and they were not found in 200 control subjects from our cohort.

![PCR--Sanger sequencing validating the candidate *EYS* variants in the retinitis pigmentosa family 1 (RP-F1) and RP-F2 DNA sequencing profiles of the identified mutations (upper) and their wild-type form (lower). Red arrows indicate the position of the mutated nucleotide. **A,B**: From RP-F1; **C,D**: from RP-F2.](mv-v25-35-f4){#f4}

WES analysis in sporadic RP patients
------------------------------------

To extend the discovery of variants in the *EYS* gene, 139 sporadic RP patients were screened by WES analysis. Fourteen *EYS* variants were identified in 18 Chinese sporadic RP patients ([Table 4](#t4){ref-type="table"}), including seven novel variants and seven previously reported variants. Novel frameshift variants (c.8301dupT:p.Asp2767fs and c.9437_9440del:p.Glu3146fs) were discovered in three independent sporadic RP patients, whereas other novel variants were found in only one RP patient. All novel variants were validated by Sanger sequencing analysis. The previously reported variant c.6416G\>A:p.Cys2139Tyr in exon 31 was found in eight sporadic RP patients. Two sporadic patients carried homozygous *EYS* variants, seven had compound heterozygous *EYS* variants, and nine had only one *EYS* variant.

###### [Table 4](#t4){ref-type="table"}. Variant identification by whole exome sequencing analysis in sporadic RP patients.

  Patients ID                                                                            Gene             Chromosome position                                                                        Novelty                                                                                    Nucleotide change       Amino acid Change   Polyphen2 HDIV   SIFT   Mutation Taster   Frequency     Genotype       
  -------------------------------------------------------------------------------------- ---------------- ------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------ ----------------------- ------------------- ---------------- ------ ----------------- ------------- -------------- --------------
  Patients carried one EYS variant or together with variants from other known RP genes                                                                                                                                                                                                                                                                                                                             
  J-RP007                                                                                *EYS*            Chr6:64431689                                                                              Novel                                                                                      c.8301dupT(Insert A)    p.Asp2767fs         .                .      .                               .              Heterozygous
  J-RP013                                                                                *ZNF513*         Chr2:27601385                                                                              rs200255167                                                                                c\. 748C\>T             p.Arg250Trp         D                D      N                 0.000998403   0.0003         Heterozygous
  *EYS*                                                                                  Chr6:64431689    novel                                                                                      c\. 8297G\>C                                                                               p.Gly2766Ala            D                   D                D      .                 .             Heterozygous   
  J-RP021                                                                                *EYS*            Chr6:64431689                                                                              PMID:24652164                                                                              c\. 8868C\>A            p.Tyr2956X          .                T      D                 .             .              Heterozygous
  J-RP011                                                                                *CRB1*           Chr1:197313422                                                                             rs114846212                                                                                c\. 457G\>A             p.Glu153Lys         D                D      D                 0.00139776    0.0007         Heterozygous
  *USH2A*                                                                                Chr1:216138711   rs200038092                                                                                c\. 7068T\>G                                                                               p.Asn2356Lys            P                   T                D      0.00159744        0.0008        Heterozygous   
  *GUCA1B*                                                                               Chr6:42162429    Reported in database                                                                       c\. 130C\>T                                                                                p.Arg44Cys              D                   D                D      .                 0.0000992     Heterozygous   
  *EYS*                                                                                  Chr6:64431689    PMC4911908                                                                                 c\. 6416G\>A                                                                               p.Cys2139Tyr            D                   D                D      .                 0.00005274    Heterozygous   
  J-RP111                                                                                *MAK*            Chr6:10773343                                                                              Novel                                                                                      .                       .                   .                .      .                 .             .              Heterozygous
                                                                                         *EYS*            Chr6:64431689                                                                              Novel                                                                                      c\. 8907T\>G            p.Cys2969Trp        D                D      D                 .             .              Heterozygous
  RP016                                                                                  *USH2A*          Chr12:16019180                                                                             rs144892841                                                                                c\. 9041C\>A            p.Thr3014Asn        D                T      D                 0.000399361   0.0001         Heterozygous
                                                                                         *EYS*            Chr6:64431689                                                                              PMID:22302105                                                                              ./ splicing             .                   .                .      D                 .             .              Heterozygous
  Patients carried homozygous or compound heterozygous *EYS* variant                                                                                                                                                                                                                                                                                                                                               
  J-RP028                                                                                *EYS*            Chr6:64431689                                                                              Novel                                                                                      c.8301dupT(Insert A)    p.Asp2767fs         .                .      .                 .             .              Heterozygous
  *EYS*                                                                                  Chr6:64431689    PMID:24652164                                                                              c\. 8012T\>A                                                                               p.Leu2671X              .                   .                D      .                 .             Heterozygous   
  *EYS*                                                                                  Chr6:64431689    PMID: 25,753,737                                                                           c\. 6416G\>A                                                                               p.Cys2139Tyr            D                   D                D      .                 0.00005274    Heterozygous   
  J-RP031                                                                                *EYS*            Chr6:64431689                                                                              Novel                                                                                      c.9437_9440del (AGTT)   p.Glu3146fs         .                .      .                 .             .              Heterozygous
  *EYS*                                                                                  Chr6:64431689    PMC4911908                                                                                 ./splicing                                                                                 .                       .                   .                D      .                 .             Heterozygous   
  *FSCN2*                                                                                Chr17:79495999   Reported in database                                                                       c\. 442C\>T                                                                                p.Arg148Trp             D                   D                D      .                 0.0008        Heterozygous   
  J-RP039                                                                                *EYS*            Chr6:64431689                                                                              PMID: 25,753,737                                                                           c\. 6416G\>A            p.Cys2139Tyr        D                D      D                 0.00005274    0              Heterozygous
  J-RP057                                                                                *EYS*            Chr6:64431689                                                                              Novel                                                                                      c\. 490C\>T             p.Arg164X           .                .      A                 .             .              Heterozygous
  *SPATA7*                                                                                                Novel                                                                                      c.20_23del(TCAG)                                                                           p.Val7fs                .                   .                .      .                 .             Heterozygous   
  J-RP059                                                                                *EYS*            Chr6:64431689                                                                              DOI:[10.3760/cma.j.issn.1674-845X.2016.01.006](10.3760/cma.j.issn.1674-845X.2016.01.006)   c\. 8012T\>A            p.Leu2671X          .                .      D                 .             .              Heterozygous
  *EYS*                                                                                  Chr6:64431689    PMID: 25,753,737                                                                           c\. 6416G\>A                                                                               p.Cys2139Tyr            D                   D                D      .                 0.00005274    Homozygous     
  J-RP066                                                                                *EMC1*           Chr1:19577999                                                                              Reported in database                                                                       c\. 5C\>T               p.Ala2Val           D                D      D                 .             0.0001         Heterozygous
  *FAM161A*                                                                              Chr2:62067223    rs183615774                                                                                c\. 916C\>T                                                                                p.Arg306Trp             D                   D                D      0.000798722       0.0002        Heterozygous   
  *PDE6B*                                                                                Chr4:619675      Novel                                                                                      c\. 260T\>C                                                                                p.Leu87Pro              D                   D                D      .                 0.0000845     Heterozygous   
  *TULP1*                                                                                Chr6:35471544    Novel                                                                                      c\. 1194C\>G                                                                               p.Ser398Arg             D                   D                D      .                 0.00003798    Heterozygous   
  *EYS*                                                                                  Chr6:64431689    rs184722374                                                                                c.9437_9440del(AGTT)                                                                       p.Glu3146fs             .                   .                .      .                 .             Heterozygous   
  *EYS*                                                                                  Chr6:64431689    Reported in database                                                                       c\. 8170G\>T                                                                               p.Glu2724X              .                   .                D      0.000199681       0.00005069    Heterozygous   
  J-RP069                                                                                *EYS*            Chr6:64431689                                                                              Novel                                                                                      c\. 9052T\>C            p.Trp3018Arg        D                D      D                 .             .              Heterozygous
  *EYS*                                                                                  Chr6:64431689    DOI:[10.3760/cma.j.issn.1674-845X.2016.01.006](10.3760/cma.j.issn.1674-845X.2016.01.006)   c\. 8012T\>A                                                                               p.Leu2671X              .                   .                D      .                 .             Heterozygous   
  *EYS*                                                                                  Chr6:64431689    PMID: 25,753,737                                                                           c\. 6416G\>A                                                                               p.Cys2139Tyr            D                   D                D      .                 0.00005274    Heterozygous   
  J-RP092                                                                                *EYS*            Chr6:64431689                                                                              PMC4911908                                                                                 c\. 6557G\>A            p.Glu2186Glu        P                P      D                 .             .              Heterozygous
  *EYS*                                                                                  Chr6:64431689    PMID: 25,753,737                                                                           c\. 6416G\>A                                                                               p.Cys2139Tyr            D                   D                D      .                 0.00005274    Heterozygous   
  J-RP122                                                                                *EYS*            Chr6:64431689                                                                              Novel                                                                                      c.9437_9440del (AGTT)   p.Glu3146fs         .                .      .                 .             .              Heterozygous
  *EYS*                                                                                  Chr6:64431689    rs184722374                                                                                c\. 8170G\>T                                                                               p.Glu2724X              .                   .                D      0.000199681       0.00005069    Heterozygous   
  *IMPDH1*                                                                               Chr7:128040533   Novel                                                                                      c\. 310G\>T                                                                                p.Asp104Tyr             D                   D                D      .                 .             Heterozygous   
  J-RP131                                                                                *C2orf71*        Chr2:29297043                                                                              rs201706430                                                                                c\. 85C\>T              p.Arg29Trp          D                D      N                 0.000199681   0.0003         Heterozygous
  *EYS*                                                                                  Chr6:64431689    DOI:[10.3760/cma.j.issn.1674-845X.2016.01.006](10.3760/cma.j.issn.1674-845X.2016.01.006)   c\. 8012T\>A                                                                               p.Leu2671X              .                   .                D      .                 .             Heterozygous   
  *EYS*                                                                                  Chr6:64431689    PMID: 25,753,737                                                                           c\. 6416G\>A                                                                               p.Cys2139Tyr            D                   D                D      .                 0.00005274    Heterozygous   
  *PRPF6*                                                                                Chr20:62663398   Reported in database                                                                       ./ splicing                                                                                .                       .                   .                D      .                 .             Heterozygous   
  RP020                                                                                  *EYS*            Chr6:64431689                                                                              Novel                                                                                      c.8301dupT (Insert A)   p.Asp2767fs         .                .      .                 .             .              Heterozygous
  *EYS*                                                                                  Chr6:64431689    rs150951106                                                                                c\. 3489T\>A                                                                               p.Asn1163Lys            D                   T                D      0.00179712        0.0004        Heterozygous   
  RP022                                                                                  *EYS*            Chr6:64431689                                                                              Novel                                                                                      c.4908delA              p.Ala1636fs         .                .      .                 .             .              Homozygous

In addition to the *EYS* variants, 12 heterozygous variants of other inherited retinal dystrophy genes were identified in seven sporadic patients ([Table 4](#t4){ref-type="table"}). Six of the genes were inherited in an autosomal dominant manner, including *CRB1*, *FSCN2*, *GUCA1B*, *IMPDH1*, *PDE6B*, and *RPRF6*. Other autosomal recessive RP genes would be unlikely to cause RP in these patients because of heterozygous carriers.

Bioinformatics analyses
-----------------------

In silico analyses by SIFT, Polyphen2, and MutationTaster bioinformatics programs showed that all identified *EYS* variants were predicted to be deleterious or possibly damaging ([Table 3](#t3){ref-type="table"} and [Table 4](#t4){ref-type="table"}). Most of the variants are located at the C-terminal of the EYS protein. The novel variants are localized in the region between the third and the fifth LamG domain at the C-terminal of the EYS protein ([Figure 5](#f5){ref-type="fig"}).

![Localization of identified mutations in the schematic structure of EYS protein.](mv-v25-35-f5){#f5}

Discussion
==========

In the present study, eight novel and seven reported variants were identified in the *EYS* gene by WES analysis in three Chinese autosomal recessive RP families and 139 sporadic patients. The human *EYS* gene is a homolog of the Drosophila eye spacemaker (SPAM) gene. EYS protein specifically expressed in the photoreceptor cell layer of the retina, and it is essential for the development and morphology of photoreceptors \[[@r11]\]. Currently, more than 270 variants have been reported in *EYS* for autosomal recessive RP patients \[[@r5]\], and the mutations include missense, nonsense, insertion, deletion, and splice site mutations \[[@r12]-[@r14]\]. The EYS protein contains 3,165 amino acids encoded by 43 exons, which is composed of 21 epidermal growth factor (EGF)-like domains, EGF-like and laminin A G-like domains; CA-calcium-binding domains and 5 LamG domains \[[@r15]\]. In addition, patients carrying *EYS* mutations progress more rapidly than those with RP caused by other autosomal recessive genes, such as *USH2A* and *MAK* \[[@r16]\].

One novel mutation, c.7492G\>C:p.Ala2498Pro, was identified in family RP-F1, which caused an amino acid change from alanine into proline. This could influence the proper folding of protein, and thus, the protein function could be affected. This variant was also confirmed by in silico prediction ([Table 3](#t3){ref-type="table"}). The heterozygous carrier of this mutation did not show any observable RP symptom. Because of the autosomal recessive inheritance, the second *EYS* mutation is c.8422G\>A:p.Ala2808Thr in the affected family members. This variant has been reported in an Indian autosomal recessive RP family with another *EYS* variant, c.7868G\>A:p.Gly2623Glu \[[@r12]\]. This further support the causal role of our novel *EYS* mutation, c.7492G\>C:p.Ala2498Pro, in autosomal recessive RP.

In the family RP-F2, compound homozygous variants (nonsense c.8012T\>A:p.Leu2671X and missense c. 6416G\>A:p.Cys2139Tyr) are the causative mutations for the autosomal recessive RP ([Figure 1B](#f1){ref-type="fig"}). Comparatively, in the family RP-F3, the same mutations but expressed in a compound heterozygous manner caused the RP phenotype, which has also been reported in other Chinese RP families \[[@r1],[@r17]\]. This could be explained by the mutations locating in the same allele in RP-F2 but different alleles in RP-F3. Moreover, the onset age of patients from RP-F2 with compound homozygous mutations was younger than that from RP-F3 with compound heterozygous mutations. The missense mutation in RP-F3 could still contain some EYS protein function compared with the truncating protein in RP-F2. This was also observed in another Chinese autosomal recessive RP family and other sporadic RP patients, in which the patients with a nonsense mutation p.\[Arg164\*\] showed an earlier age of onset than those without this mutation \[[@r1],[@r3],[@r17]\].

Most of the variants are localized at the C-terminus of the EYS protein ([**Figure 5**](#f5){ref-type="fig"}). Some nonsense mutations (p.Leu2671X and p.Tyr2956X) cause truncation in the EYS protein and partially delete the LamG domains. Other truncating mutations, such as p.Ala1636fs and p.Asp2767fs, could be insertions or deletions. Previous studies showed that the LamG domain is required for EYS function in interrhabdomeral space formation \[[@r5]\]. Therefore, these mutations could affect the EYS functions through disruption of the LamG domain. The C-terminus localization of *EYS* mutations has also been reported in other studies \[[@r5],[@r6],[@r12],[@r13]\]. However, variants from a cohort of Spanish origin did not exhibit this trend \[[@r18]\].

Homozygous or compound heterozygous *EYS* mutations were also identified in sporadic RP patients from our study ([Table 4](#t4){ref-type="table"}). The frequency of RP patients with *EYS* mutations was 6.47% (9/139) in our cohort. *EYS* mutations are common in RP \[[@r12]-[@r17]\]. The variant c.6416G\>A:p.Cys2139Tyr was not only frequently found in RP patients in our cohort, but it is also frequently identified in other populations \[[@r13],[@r19]\]. Nevertheless, further investigations are required to delineate the pathological functions of our novel *EYS* mutations.

In summary, this study revealed eight novel and seven reported mutations in the *EYS* gene in Chinese autosomal recessive RP families and sporadic RP patients through WES analysis. Our results further expand the spectrum of *EYS* variants in RP and further confirm the reported mutations. Genetic diagnosis is a critical strategy for aiding clinical diagnosis to bring about better clinical management and counseling. It should be recommended as a routine examination for RP patients.
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